Loading...
Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis
BACKGROUND: Verification of cerebrospinal fluid (CSF) biomarkers for multiple sclerosis and other neurological diseases is a major challenge due to a large number of candidates, limited sample material availability, disease and biological heterogeneity, and the lack of standardized assays. Furthermo...
Na minha lista:
| Udgivet i: | Clin Proteomics |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7499868/ https://ncbi.nlm.nih.gov/pubmed/32963504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-020-09296-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|